Integrative transcriptomic, proteomic, and machine learning approach to identifying feature genes of atrial fibrillation using atrial samples from patients with valvular heart disease
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Feature selection and Naive Bayes classification integrated atrial transcriptomic/proteomic data, identifying candidate AF-associated genes and reporting high held-out classification performance; samples came from valvular-heart-disease patients.
Technology: Feature selection and Naive Bayes classification integrate atrial transcriptomic/proteomic data to identify atrial-fibrillation-associated genes and classify samples.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Feature selection and Naive Bayes classification integrate atrial transcriptomic/proteomic data to identify atrial-fibrillation-associated genes and classify samples.
- Limitation / still unknown
- Validation or comparison reported in the source was checked and the conclusion is limited to that design and cohort; caveats noted in reason.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1186/s12872-020-01819-0 · https://europepmc.org/article/MED/33509101 · https://europepmc.org/articles/PMC7842070 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC7842070/unicode · https://pubmed.ncbi.nlm.nih.gov/33509101/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.